Researchers analyzed data from thousands of patients with axial psoriatic arthritis and axial spondyloarthritis. These are two conditions that often share similar symptoms and clinical features. The study looked at several factors, including disease activity scores, physical function, and certain blood markers.
While most clinical measures like inflammation levels and daily function were very similar between the two groups, one major difference was found in a gene called HLA-B27. Patients with axial psoriatic arthritis had significantly lower rates of this specific marker compared to those with axial spondyloarthritis.
Because these conditions look so similar on the surface, doctors may find it hard to tell them apart during a routine exam. This finding suggests that testing for HLA-B27 and using imaging could help specialists provide more specific care. However, because this is based on observational data, it shows a link rather than a direct cause.
Common questions
How are these two types of arthritis different?
Most clinical features, such as disease activity scores and inflammation levels (C-reactive protein), were very similar between the two groups. However, patients with axial psoriatic arthritis showed significantly lower HLA-B27 positivity compared to those with axial spondyloarthritis.
What is the role of HLA-B27 in these conditions?
The study found a significant difference in HLA-B27 levels between the two groups. Because this marker was much lower in patients with axial psoriatic arthritis, it may help doctors distinguish between the two diseases when they appear similar.
Does this mean one condition is worse than the other?
The study did not find significant differences in most activity or functional scores. While some data showed slightly better function scores for psoriatic arthritis patients compared to those with ankylosing spondylitis, the results were mostly similar across both groups.
